883 results on '"LePage C"'
Search Results
2. Quel bilan à deux ans de la mise en place de l’accompagnement des patients traités par anti-vitamines K ? Le point de vue du pharmacien d’officine
3. Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial
4. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
5. Apport de la volumétrie au rajeunissement facial. Partie 2 : produits de comblement
6. Apport de la volumétrie au rajeunissement facial. Partie 1 : greffe adipocytaire
7. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort
8. Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
9. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)
10. Annual cycle of Whitewinged Scoters (Melanitta fusca)in eastern North America: migratory phenology, population delineation, and connectivity
11. Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study
12. Chimiothérapie par oxaliplatine normalisée à la quantité de masse maigre pour des cancers du côlon de stade III traités en adjuvant : impact sur les neurotoxicités à partir d’une étude randomisée multicentrique de phase II (LEANOX)
13. Sporadic non-functional neuroendocrine pancreatic incidentalomas (NF-NEI) ≤ 2 cm: risk of progression over 3 years. Results of the prospective multicenter French national study IPANEMA
14. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona
15. Ipsilateral breast cancer recurrence after Deep Inferior Epigastric Perforator (DIEP) flap reconstruction: Incidence and radiological presentation
16. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
17. Mise en place d’une activité de reconstruction microchirurgicale du sein par tissus autologues. Évolution sur 20 ans et revue de 1138 cas
18. La part positionnelle de la personne polyhandicapée en grande dépendance
19. Épidémiologie des tumeurs neuroendocrines intestinales
20. Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
21. Toxicités cutanées et efficacité de l’enfortumab vedotin. Expérience monocentrique en vie réelle
22. Comment différencier un ‘vrai’ d’un ‘faux’ VIPome : étude nationale multicentrique du GTE-ENDOCAN-RENATEN avec test d’interférence biologique
23. MPI Parallelization of Unstructured Mesh Adaptation
24. LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
25. LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial
26. Author's reply: “Management of anal squamous cell carcinoma and its recurrences”
27. 321P A comprehensive predicting model of recurrence in stage III colon cancer from PETACC-8 trial
28. Improvement in survival of metastatic colorectal cancer: Are the benefits of clinical trials reproduced in population-based studies?
29. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer
30. 1447P Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
31. 594P Genetic and transcriptomic analyses of Early-Onset Colon Cancer (EOCC): A post-hoc analysis of 2973 patients (pts) from two adjuvant randomized trials
32. 572P Tolerance of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34 – FFCD 1402 - ADAGE randomized phase III trial
33. 507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial
34. 502O Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial
35. Lichenoid eruption during antiPD-L1 immunotherapy with avelumab in metastatic colorectal cancer
36. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002
37. Diminution significative des volumes de drainage postopératoires en reconstruction mammaire différée par lambeau libre DIEP par utilisation de colle de fibrine
38. OC-0270 Final results of the French national cohort ANABASE : treatment and outcome in anal cancer
39. Economic Theory of Renewable Resource Management: A Multi-agent System Approach
40. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells
41. Analyse médico-économique du lambeau libre de DIEP en reconstruction mammaire
42. Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"
43. Cancer du côlon : bilan et surveillance
44. Non-Pharmaceutical Interventions for Self-Regulatory Failures in Adolescents Suffering from Externalizing Symptoms: A Scoping Review
45. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis
46. Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds
47. 391MO Impact of diabetes and metformin use on recurrence and outcome in early colon cancer (CC) patients: A pooled analysis of 3 adjuvant trials
48. LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)
49. PH-0113 Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904)
50. A collaborative resource platform for non-human primate neuroimaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.